Skip to main content
Fig. 7 | EJNMMI Radiopharmacy and Chemistry

Fig. 7

From: Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology

Fig. 7

a Biodistribution results of (from left to right): GRPR-specificity (black bars), [111In]In-Au-SAR-M1 at 4 h (blue bars) and 24 h (red bars). Results are given as average %IA/g ± sd (error bars), ** = p < 0.01; **** = p < 0.0001. b T/O ratios for [111In]In-AU-SAR-M1 at 4 h pi (blue bars) and 24 h pi (red bars), given as mean values ± sd (as error bars), n = 4 for both groups

Back to article page